Pure Global
NCT05748795

Microbial Colonization in Lung Cancer Patients

Assiut University·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
bronchoscopy brochoalveolar lavage
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Assiut University
Location
Assiut, Egypt
Timeline & enrollment
Phase
N/A
Start date
Feb 01, 2023
End date
Feb 01, 2024
Enrollment
103 participants
Primary outcome

Prevalence of microbial colonization among the study population:,Predictors of microbial colonization among the study population:

Summary

Primary Aim:
 
 -To determine the prevalence and pattern of bronchial colonization in patients presenting
 with lung cancer at the time of diagnosis
 
 Secondary Aim:
 
 -To assess the potential demographic, clinical, radiological and histological predictors of
 colonization in patients with lung cancer

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05748795
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05748795 through Pure Global AI's free database. This phase not specified trial is sponsored by Assiut University and is currently Recruiting. The study focuses on Microbial Colonization. Target enrollment is 103 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.